pharma · Kidney Diseases
Huadong Medicine Co
Hangzhou Zhongmei Huadong Pharmaceutical Co.,
Hangzhou Zhongmei Huadong is a pharma organization headquartered in CN. Primary therapeutic focus areas include Kidney Diseases. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to th
Hangzhou, CN HQ
1993 Founded
26 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Hangzhou, CN
- Founded
- 1993
- Employees
- 26
- Programs
- 1
- Drugs
- 1
- Patents
- 0
MB-102 DMID
Phase 3 · small molecule · Kidney Diseases
MB-102 DMID for Kidney Diseases is a Phase 3 program (small_molecule) at Hangzhou Zhongmei Huadong Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code HDNP102-301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co.,
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Kidney Diseases
- Status
- completed
- Trials
- 1